Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer-Reference-Cited by-同舟云学术

Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer

Published:2001-11 Issue:11 Volume:12 Page:1545-1551
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fountzilas G.,Tsavdaridis D.,Kalogera-Fountzila A.,Christodoulou Ch.,Timotheadou E.,Kalofonos Ch.,Kosmidis P.,Adamou A.,Papakostas P.,Gogas H.,Stathopoulos G.,Razis E.,Bafaloukos D.,Skarlos D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/11/1545/19478888/12-11-1545.pdf

Reference33 articles.

1. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer;Holmes;J Natl Cancer Inst,1991

2. Phase II trial of paclitaxel by three-hour infusion as initial and salvage chemotherapy for metastatic breast cancer;Seidman;J Clin Oncol,1995

3. Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer;Nabholtz;J Clin Oncol,1996

4. Paclitaxel in doxorubicin refractory or mitoxantrone refractory breast cancer A phase I–II trial of 96-hour infusion;Wilson;J Clin Oncol,1994

5. A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines;Fountzilas;Eur J Cancer,1996

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu;Gynecologic Oncology;2021-10

2. Pulmonary Toxicities of Targeted Therapy;Handbook of Cancer Treatment-Related Symptons and Toxicities;2020

3. Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy;Polymers;2018-02-14

4. Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study;Breast Cancer: Targets and Therapy;2016-12

5. The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer;BMC Neurology;2016-10-01